Results 281 to 290 of about 116,257 (347)
ABSTRACT Aim Recruiting participants for neonatal clinical studies may be challenging because parental consent is required shortly after birth. This study aimed to explore reasons for parental decline of participation in a neonatal study. Method This qualitative sub‐study was conducted in the Capital Region of Denmark between June 2022 and April 2023 ...
Susanne Soendergaard Kappel +5 more
wiley +1 more source
ABSTRACT Flavobacterium psychrophilum, the etiological agent of Rainbow Trout Fry Syndrome (RTFS) and Bacterial Coldwater Disease (BCWD), causes varying degrees of disease and mortality in salmonid aquaculture worldwide. Because its treatment relies on the use of antimicrobials, alternative interventions are of environmental and economic interest.
Valentina L. Donati +2 more
wiley +1 more source
Current Clinical Laboratory Challenges to Widespread Adoption of Phage Therapy in the United States. [PDF]
Kline A +6 more
europepmc +1 more source
ABSTRACT Objectives Periodontal disease, a global health concern, is strongly associated with oral treponemes. However, the taxonomy of some species remains unresolved, hindering our understanding of their roles in disease. This study aims to clarify the taxonomy of three strains isolated from patients with periodontal disease using phylogenomic and ...
Jordan Y. H. Fong +7 more
wiley +1 more source
Macrophage-induced reduction of bacteriophage density limits the efficacy of in vivo pulmonary phage therapy. [PDF]
Zborowsky S +11 more
europepmc +1 more source
Deregulated enhancer‐promoter communication in cancer through altered nuclear architecture
Abstract Enhancers are critical regulators of gene expression. Structural variations in cancer genomes can lead to enhancer hijacking, where oncogenes are activated by mistargeted enhancer activity. Novel enhancer‐promoter interactions may also arise through chromosomal rearrangements that create extrachromosomal DNA elements.
Isabelle Seufert +3 more
wiley +1 more source
Phage-specific antibodies: are they a hurdle for the success of phage therapy? [PDF]
Washizaki A, Sakiyama A, Ando H.
europepmc +1 more source
Ethical argument for establishing good manufacturing practice for phage therapy in the UK. [PDF]
Suleman M, Clark JR, Bull S, Jones JD.
europepmc +1 more source
PHAGE THERAPY: THE USE OF BACTERIOPHAGES AGAINST INFECTIONS
Sahand Ebadi Shalke
openalex +1 more source

